Morgan Stanley Intercept Pharmaceuticals, Inc. Transaction History

Morgan Stanley

  • $1.27 Trillion
  • Q2 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023
BUY
$9.99 - $18.71 $4.34 Million - $8.14 Million
434,872 Added 306.46%
576,774 $10.7 Million
Q2 2023

Aug 14, 2023
SELL
$9.17 - $19.29 $2.07 Million - $4.36 Million
-225,879 Reduced 61.42%
141,902 $1.57 Million
Q1 2023

May 15, 2023
SELL
$12.53 - $21.71 $5.07 Million - $8.78 Million
-404,599 Reduced 52.38%
367,781 $4.94 Million
Q4 2022

Feb 14, 2023
SELL
$11.61 - $16.11 $1.46 Million - $2.02 Million
-125,593 Reduced 13.99%
772,380 $9.55 Million
Q3 2022

Nov 14, 2022
SELL
$12.21 - $19.7 $1.99 Million - $3.21 Million
-163,196 Reduced 15.38%
897,973 $12.5 Million
Q2 2022

Oct 27, 2022
BUY
$11.23 - $19.59 $5.56 Million - $9.69 Million
494,677 Added 87.32%
1,061,169 $14.7 Million
Q2 2022

Aug 15, 2022
BUY
$11.23 - $19.59 $5.56 Million - $9.69 Million
494,677 Added 87.32%
1,061,169 $14.7 Million
Q1 2022

Oct 27, 2022
SELL
$13.37 - $17.79 $6.61 Million - $8.8 Million
-494,677 Reduced 46.62%
566,492 $9.22 Million
Q1 2022

May 13, 2022
BUY
$13.37 - $17.79 $4.98 Million - $6.63 Million
372,527 Added 192.06%
566,492 $9.22 Million
Q4 2021

Feb 14, 2022
BUY
$14.28 - $19.53 $304,006 - $415,774
21,289 Added 12.33%
193,965 $3.16 Million
Q3 2021

Nov 15, 2021
BUY
$12.99 - $20.47 $2.24 Million - $3.53 Million
172,676 New
172,676 $2.56 Million

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email